The development of new cancer drugs: a joint venture in public policy by the National Cancer Institute and Food and Drug Administration.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000592:standards*; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D000882:Haplorhini; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D011640:Public Policy; D012107:Research Design; D014481:United States
D000970:Antineoplastic Agents